These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30031973)

  • 1. Corrigendum to "Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents" [Eur. J. Med. Chem. 152 (2018) 148-159].
    Ghoshal A; Kumar A; Yugandhar D; Sona C; Kuriakose S; Nagesh K; Rashid M; Singh SK; Wahajuddin M; Yadav PN; Srivastava AK
    Eur J Med Chem; 2018 Aug; 156():628-630. PubMed ID: 30031973
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents.
    Ghoshal A; Kumar A; Yugandhar D; Sona C; Kuriakose S; Nagesh K; Rashid M; Singh SK; Wahajuddin M; Yadav PN; Srivastava AK
    Eur J Med Chem; 2018 May; 152():148-159. PubMed ID: 29704723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Search for new multi-target compounds against Alzheimer's disease among histamine H
    Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B
    Eur J Med Chem; 2020 Nov; 205():112611. PubMed ID: 32791398
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Discovery of novel 3-hydroxyandrosta-5,7-Diene-17-Carboxylic acid derivatives as anti-inflammatory bowel diseases (IBD) agents" [Eur. J. Med. Chem. 220 (2021), 113468].
    Chen J; Li L; Liu J; Yuan S; Liao W; Slominski AT; Li W; Zmijewski MA; Chen J
    Eur J Med Chem; 2024 Oct; 276():116718. PubMed ID: 39069438
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Synthesis and cytotoxic activity of novel A-ring cleaved ursolic acid derivatives in human non-small cell lung cancer cells" [Eur. J. Med. Chem. 123 (2016) 317-331].
    Mendes VIS; Bartholomeusz GA; Ayres M; Gandhi V; Salvador JAR
    Eur J Med Chem; 2016 Nov; 124():1004-1005. PubMed ID: 27783971
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Photocytotoxic oxovanadium(IV) complexes of ferrocenyl-terpyridine and acetylacetonate derivatives" [Eur. J. Med. Chem. 92 (2015) 332-341].
    Balaji B; Balakrishnan B; Perumalla S; Karande AA; Chakravarty AR
    Eur J Med Chem; 2019 Aug; 175():1. PubMed ID: 31055148
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity" [Eur. J. Med. Chem. 55 (2012) 220-227].
    Chen KF; Tai WT; Hsu CY; Huang JW; Liu CY; Chen PJ; Kim I; Shiau CW
    Eur J Med Chem; 2018 Jan; 143():2015. PubMed ID: 29113744
    [No Abstract]   [Full Text] [Related]  

  • 8. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
    Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "Synthesis and preliminary antiproliferative activity of new pteridin-7(8H)-one derivatives" [Eur. J. Med. Chem. 143 (2018) 1396-1405].
    Li ZH; Zhao TQ; Liu XQ; Zhao B; Wang C; Geng PF; Cao YQ; Fu DJ; Jiang LP; Yu B; Liu HM
    Eur J Med Chem; 2019 Nov; 181():111387. PubMed ID: 31376565
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Design, synthesis, DFT study and antifungal activity of the derivatives of pyrazolecarboxamide containing thiazole or oxazole ring" [Eur. J. Med. Chem. 149 (2018) 170-181].
    Yan Z; Liu A; Huang M; Liu M; Pei H; Huang L; Yi H; Liu W; Hu A
    Eur J Med Chem; 2018 May; 152():392. PubMed ID: 29747120
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives to reduce SREBPs expression for the treatment of hyperlipidemia" [Eur. J. Med. Chem. 221 (2021) 113522].
    Ge H; Zhang W; Yuan K; Xue H; Cheng H; Chen W; Xie Y; Zhang J; Xu X; Yang P
    Eur J Med Chem; 2022 Jan; 228():114041. PubMed ID: 34902733
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "New desulfured troglitazone derivatives: Improved synthesis and biological evaluation" [Eur. J. Med. Chem. 187 (2020) 111939].
    Dupommier D; Muller C; Comoy C; Mazerbourg S; Bordessa A; Piquard E; Pawlak M; Piquard F; Martin H; De Fays E; Grandemange S; Flament S; Boisbrun M
    Eur J Med Chem; 2020 Dec; 208():112834. PubMed ID: 32966897
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Design, synthesis, and biological evaluation of 1,6-naphthyridine-2-one derivatives as novel FGFR4 inhibitors for the treatment of colorectal cancer" [Eur. J. Med. Chem. 259 (2023) 115703/5].
    Fang B; Lai Y; Yan H; Ma Y; Ni Z; Zhu Q; Zhang J; Ye Y; Wang M; Wang P; Wang Y; Zhang S; Hui M; Wang D; Zhao Y; Li X; Wang K; Liu Z
    Eur J Med Chem; 2024 Mar; 268():116230. PubMed ID: 38368135
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease" [Eur. J. Med. Chem. 163 (2019), 307-319. DOI: 10.1016/j.ejmech.2018.11.040].
    Tang YW; Shi CJ; Yang HL; Cai P; Liu QH; Yang XL; Kong LY; Wang XB
    Eur J Med Chem; 2024 Sep; 275():116591. PubMed ID: 38890013
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Structure-guided identification of novel dual-targeting estrogen receptor α degraders with aromatase inhibitory activity for the treatment of endocrine-resistant breast cancer" [Eur. J. Med. Chem. 253 (2023) 115328].
    Xin L; Min J; Hu H; Li Y; Du C; Xie B; Cheng Y; Deng X; Deng X; Shen K; Huang J; Chen CC; Guo RT; Dong C; Zhou HB
    Eur J Med Chem; 2024 Oct; 276():116713. PubMed ID: 39068107
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors" [Eur. J. Med. Chem. 181 (2019) 111562].
    Gaines T; Garcia F; Virani S; Liang Z; Yoon Y; Oum YH; Shim H; Mooring SR
    Eur J Med Chem; 2023 Dec; 261():115753. PubMed ID: 37634992
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents" [Eur. J. Med. Chem. 162 (162) (2019) 203-211].
    Su L; Li J; Zhou Z; Huang D; Zhang Y; Pei H; Guo W; Wu H; Wang X; Liu M; Yang CG; Chen Y
    Eur J Med Chem; 2019 Apr; 168():385. PubMed ID: 30826513
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity" [Eur. J. Med. Chem. 138 (2017) 128-139].
    Desantis J; Nannetti G; Massari S; Barreca ML; Manfroni G; Cecchetti V; Palù G; Goracci L; Loregian A; Tabarrini O
    Eur J Med Chem; 2018 Aug; 156():302-303. PubMed ID: 30007243
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer" [Eur. J. Med. Chem. 163 (2019) 787-803].
    Wang C; Wang B; Hou S; Xue L; Kang Z; Du J; Li Y; Liu X; Wang Q; Zhang C
    Eur J Med Chem; 2020 Jan; 186():111907. PubMed ID: 31791642
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis" [Eur. J. Med. Chem 209 (2021) 112942].
    Faraji A; Oghabi Bakhshaiesh T; Hasanvand Z; Motahari R; Nazeri E; Boshagh MA; Firoozpour L; Mehrabi H; Khalaj A; Esmaeili R; Foroumadi A
    Eur J Med Chem; 2021 Mar; 214():113228. PubMed ID: 33550180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.